Abbott Diabetes Care Recalls Blood Glucose Test Strips

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Abbott Diabetes Care (NYSE:ABT) said it issued a recall of its FreeStyle blood glucose test strips after reports of falsely low results. The Alameda, Calif.-based medical device company found that the FreeStyle test strips used with Insulet's (NSDQ:PODD) OmniPod glucose management system and its own FreeStyle and FreeStyle Flash glucose meters were reporting "erroneously low blood glucose results," according to a press release. Abbott is asking customers call its customer service line for replacement strips and to use alternative methods of measuring blood glucose in the meantime. Affected strips are to be disposed of in a normal fashion.

Help employers find you! Check out all the jobs and post your resume.

Back to news